agilon health, inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $AGL in the last 30 days.
See all $AGL insider activity →ADARx (ADRX) priced its IPO at $17/share, raising $446.3M, with AbbVie investing $100M. CNSY (CNSY) secured reimbursement with Blue Cross Blue Shield. JAGX (JAGX) completed a reverse stock split. AGL (AGL) expanded its partnership with Springfield Clinic. ONCO (ONCO) agreed to acquire Realbotix. All stocks traded higher.
Dave & Buster's (PLAY) fell 11.1% due to Q2 earnings miss. Vishay (VSH) rose 2.5% on Oppenheimer's Outperform rating. DocuSign (DOCU) gained 3.9% after IDC recognition and AI news. SentinelOne (S) rose 2.9% on Latio's AI Security Platform Leader status. Agilon Health (AGL) climbed 3.9% after Bernstein SocGen's upgrade and price target raise.
Agilon Health (AGL) shares rose 3.9% after Bernstein upgraded the stock to Outperform and raised its price target to $125 from $86, citing improvements in risk management and cost control. The stock later settled at $94.74, up 2.8%. AGL is up 463% YTD but still 27% below its 52-week high.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning AGL (agilon health, inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent AGL coverage spans market movers, earnings and corporate actions.
Growth in value‑based care contracts may enhance long‑term cash flow.
Upgrade and higher target provide a bullish catalyst.
Positive analyst upgrade with a higher price target suggests near‑term upside.
Upgrade signals improving health‑care turnaround.
Despite strong operational and guidance beats, the stock’s sharp decline suggests investors are focused on valuation, profitability trajectory, or other concerns not detailed here.
AlphAI scores every news story that mentions AGL with an AI model for sentiment and relevance, and aggregates insider trades from agilon health, inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
ADARx (ADRX) priced its IPO at $17/share, raising $446.3M, with AbbVie investing $100M. CNSY (CNSY) secured reimbursement with Blue Cross Blue Shield. JAGX (JAGX) completed a reverse stock split. AGL (AGL) expanded its partnership with Springfield Clinic. ONCO (ONCO) agreed to acquire Realbotix. All stocks traded higher.
2 min readDave & Buster's (PLAY) fell 11.1% due to Q2 earnings miss. Vishay (VSH) rose 2.5% on Oppenheimer's Outperform rating. DocuSign (DOCU) gained 3.9% after IDC recognition and AI news. SentinelOne (S) rose 2.9% on Latio's AI Security Platform Leader status. Agilon Health (AGL) climbed 3.9% after Bernstein SocGen's upgrade and price target raise.
2 min readAgilon Health (AGL) shares rose 3.9% after Bernstein upgraded the stock to Outperform and raised its price target to $125 from $86, citing improvements in risk management and cost control. The stock later settled at $94.74, up 2.8%. AGL is up 463% YTD but still 27% below its 52-week high.
2 min readAnalysts made several calls on Tuesday, including upgrades for Nokia (NOK), The New York Times (NYT), Agilon (AGL), and Eli Lilly (LLY). Price targets were raised for NYT ($82), AGL ($125), and Palantir (PLTR, $250). Other notable actions include initiations on Janus Living, Vishay Intertechnology (VSH), and Samsara (IOT).
3 min readThe article highlights Q2 results for outpatient and specialty care firms. Surgery Partners (SGRY) reported slowest revenue growth and weaker full-year guidance, with the stock down 1.4% to $15.32. LifeStance (LFST) revenue rose to $435.4M (+26.1%) and shares rose 18.3% to $12.27. U.S. Physical Therapy (USPH) revenue $214.1M (+8.5%) and shares $81.96. Encompass Health (EHC) revenue $1.60B (+9.6%) and shares $124.69. agilon health (AGL) revenue $1.49B (+7.2%), shares $87.56.
6 min readAustralia’s ASX200 is set for its worst week since April, down 0.71% to 9,123 by midday, as banks and miners fell. Materials slid over 3% as gold and copper eased. BHP shares dropped 3.8% to $61.05 ahead of results. Westpac, ANZ and CommBank flagged double-digit home-loan application declines.
6 min readAgilon Health (AGL) reported Q2 2026 revenue of $1.49B, up 7% y/y, and adjusted EBITDA of $70M, above guidance, citing favorable medical cost development and higher risk adjustment revenue. FY2026 guidance was raised to $5.78B-$5.86B revenue and $75M-$95M adjusted EBITDA. Medicare Advantage membership fell to 437k. Cash and marketable securities were $257M at June 30, 2026.
10 min readAGL Energy reported higher customer bad-debt expense after the end of Australia’s federal power bill relief ($450 for households, $475 for small businesses). Net bad-debt expense rose to 1.6% from 1.3%. AGL said it provided $27m support to 20,000 customers. Underlying net profit was $631m, down ~2%, with guidance $580m-$680m.
4 min readAustralia’s S&P/ASX 200 fell 0.59% to 9,196.3 by midday, with oil above US$90 a barrel and risk sentiment pressured by Middle East uncertainty and hawkish Fed comments ahead of CPI. Commonwealth Bank shares slid to $171.69 after Matt Comyn cautioned growth is slowing. AGL rose ~5% on higher statutory profit; Seek fell ~15% on a $201m write-down.
7 min readAGL Energy shares rose 5.4% to A$8.6 after the company reported FY26 results. Underlying EBITDA increased 2% to A$2.10 billion, operating free cash flow rose 60% to A$850 million, and profit after tax was A$756 million. It declared a fully franked final dividend of 26 cents, taking FY26 total to 50 cents, and guided FY27 payout ratio of 55–60%.
3 min read
